Fair comment. There is only a narrow window of opportunity with the current situation. On the other hand it would have been an opportunity to get the product in the market which in turn could have made it easier should they have decided to establish the IF in USA in the future. Personally I reckon the current demand in China is taking all their inventory anyway. Time will tell....
US FDA Eases Baby-Formula Import Rules to Boost US Supplies, page-58
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.70 |
Change
0.015(0.22%) |
Mkt cap ! $4.814B | |||
| Open | High | Low | Value | Volume |
| $6.66 | $6.73 | $6.65 | $1.299M | 194.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 18041 | $6.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.71 | 15879 | 17 |
View Market Depth
| Last trade - 11.37am 08/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |